Literature DB >> 19512962

Acute hemifacial dystonia possibly induced by clebopride.

Domenico Bosco1, Massimiliano Plastino, Maria Giovanna Marcello, Pasquale Mungari, Antonietta Fava.   

Abstract

Dystonic reactions produce twisting and repetitive movements or abnormal posturing. Severe dystonic reactions have been shown to occur in concert with numerous medications. This report details the case of a patient who developed hemifacial dystonia as acute side reaction from administration of clebopride for dyspeptic prophylaxis. When the drug was immediately stopped, the dystonic posture disappeared completely within 2 weeks. The use of clebopride may be associated with not only a reversible or persistent parkinsonism syndrome but also hemifacial dystonia; therefore, attention must be drawn to this possible side effect.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19512962     DOI: 10.1097/WNF.0b013e31817ec335

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  4 in total

1.  Evolution of certain typical and atypical features in a case of subacute sclerosing panencephalitis.

Authors:  Tushar Premraj Raut; Maneesh Kumar Singh; Ravindra Kumar Garg; Dheeraj Rai
Journal:  BMJ Case Rep       Date:  2012-12-23

2.  Acupuncture and related therapies used as add-on or alternative to prokinetics for functional dyspepsia: overview of systematic reviews and network meta-analysis.

Authors:  Robin S T Ho; Vincent C H Chung; Charlene H L Wong; Justin C Y Wu; Samuel Y S Wong; Irene X Y Wu
Journal:  Sci Rep       Date:  2017-09-04       Impact factor: 4.379

3.  Acute Cervical Dystonia Induced by Clebopride.

Authors:  Jin Kyo Choi; Jin Yong Hong
Journal:  Case Rep Neurol Med       Date:  2017-11-28

Review 4.  Chinese herbal medicine for functional dyspepsia: systematic review of systematic reviews.

Authors:  Michael H K Chu; Irene X Y Wu; Robin S T Ho; Charlene H L Wong; Anthony L Zhang; Yan Zhang; Justin C Y Wu; Vincent C H Chung
Journal:  Therap Adv Gastroenterol       Date:  2018-07-16       Impact factor: 4.409

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.